Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
5
×
life sciences
5
×
national blog main
san francisco blog main
boston blog main
boston top stories
eli lilly
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
medical device
migraine
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
bausch health
bladder cancer
bristol-myers squibb
cancer immunotherapy
car-t immunotherapy
deals
What
companies
5
×
drug
5
×
new
approval
bio
biotech
fda
ipo
leading
migraine
nash
news
roundup
activity
approved
arguments
big
biogen’s
biopharmaceutical
black
cancer
class
clinic
commercialized
competitors
convo
days
decades
diamond
digital
disease
dog
drugs
earlier
eluded
epidemic
failures
fatty
firm
frenzied
Language
unset
Current search:
companies
×
" life sciences "
×
drug
×
" clinical trials "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More